SUNPHARMA had a strong weekly performance, returning 1.4% and outperforming peers DRREDDY and HINDUNILVR. The stock's volatility was relatively low at 7.23%, indicating a relatively stable performance. Compared to its peers, SUNPHARMA's Sharpe Ratio of 1.54 suggests it offered a higher return per unit of risk taken. Overall, the stock's performance was impressive, with no max drawdown, making it a relatively safe bet this week.

[Volatility: 7.23%]